U.S. markets closed

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
81.41-0.57 (-0.70%)
At close: 04:00PM EST
81.94 +0.53 (+0.65%)
After hours: 06:04PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close81.98
Bid33.01 x 800
Ask92.98 x 900
Day's Range81.21 - 83.81
52 Week Range72.26 - 95.26
Avg. Volume278,375
Market Cap4.131B
Beta (5Y Monthly)0.38
PE Ratio (TTM)32.69
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HAE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Haemonetics Corporation
    HAE: Lowering target price to $87.00HAEMONETICS CORP/MASS has an Investment Rating of HOLD; a target price of $87.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more